LAUREN KARBOWSKI: Open Payments
NPI 1083238182 · GREENSBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,739 in 117 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $30 · 2025 $2,739
Food & beverage: $2,639Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 30 | $904 |
| GlaxoSmithKline, LLC. | 18 | $312 |
| Verona Pharma, Inc. | 14 | $295 |
| Regeneron Healthcare Solutions, Inc. | 8 | $223 |
| Mallinckrodt Hospital Products Inc. | 5 | $171 |
| Grifols Shared Services North America, Inc. | 2 | $167 |
| GENZYME CORPORATION | 10 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $126 |
| United Therapeutics Corporation | 4 | $99 |
| Insmed, Inc. | 5 | $88 |
Products named: DUPIXENT, FASENRA, Ohtuvayre, TEZSPIRE, NUCALA, Prolastin-C Liquid, ACTHAR, GLASSIA.
Industry payments across IN — which companies pay providers there.
